RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 14.8
(-2.63%)
EUR 14.8
(-2.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 38.71 Million EUR | 53.96% |
| 2022 | 25.14 Million EUR | -11.14% |
| 2021 | 28.29 Million EUR | 1048.8% |
| 2020 | 2.46 Million EUR | -94.31% |
| 2019 | 43.27 Million EUR | -11.67% |
| 2018 | 48.99 Million EUR | 39.38% |
| 2017 | 35.15 Million EUR | -37.71% |
| 2016 | 56.43 Million EUR | -33.91% |
| 2015 | 85.38 Million EUR | -93.03% |
| 2014 | 1.22 Billion EUR | 1314.59% |
| 2013 | 86.64 Million EUR | -3.39% |
| 2012 | 89.68 Million EUR | -42.55% |
| 2011 | 156.11 Million EUR | 7.61% |
| 2010 | 145.06 Million EUR | 10.19% |
| 2009 | 131.65 Million EUR | 7.34% |
| 2008 | 122.64 Million EUR | 15.38% |
| 2007 | 106.29 Million EUR | 1.04% |
| 2006 | 105.2 Million EUR | 25.72% |
| 2005 | 83.68 Million EUR | 9.52% |
| 2004 | 76.4 Million EUR | -4.13% |
| 2003 | 79.69 Million EUR | 6.08% |
| 2002 | 75.12 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 9.01 Million EUR | -16.51% |
| 2024 Q1 | 10.79 Million EUR | -30.57% |
| 2023 Q4 | 15.55 Million EUR | 39.21% |
| 2023 Q1 | 6.25 Million EUR | -28.56% |
| 2023 Q3 | 11.17 Million EUR | 94.92% |
| 2023 FY | 38.71 Million EUR | 53.96% |
| 2023 Q2 | 5.73 Million EUR | -8.44% |
| 2022 Q1 | 1.33 Million EUR | -90.18% |
| 2022 Q2 | 10.51 Million EUR | 687.72% |
| 2022 FY | 25.14 Million EUR | -11.14% |
| 2022 Q3 | 4.86 Million EUR | -53.72% |
| 2022 Q4 | 8.76 Million EUR | 80.01% |
| 2021 Q2 | 6.94 Million EUR | 522.22% |
| 2021 Q3 | 6.64 Million EUR | -4.31% |
| 2021 Q4 | 13.59 Million EUR | 104.51% |
| 2021 Q1 | 1.11 Million EUR | 1608.11% |
| 2021 FY | 28.29 Million EUR | 1048.8% |
| 2020 FY | 2.46 Million EUR | -94.31% |
| 2020 Q3 | 5.75 Million EUR | 2539.45% |
| 2020 Q4 | -74 Thousand EUR | -101.29% |
| 2020 Q2 | 218 Thousand EUR | 104.9% |
| 2020 Q1 | -4.44 Million EUR | -169.53% |
| 2019 Q1 | 8.33 Million EUR | 147.11% |
| 2019 FY | 43.27 Million EUR | -11.67% |
| 2019 Q2 | 11.5 Million EUR | 38.16% |
| 2019 Q3 | 17.04 Million EUR | 48.08% |
| 2019 Q4 | 6.39 Million EUR | -62.47% |
| 2018 Q2 | 7 Million EUR | -29.91% |
| 2018 Q3 | 28.62 Million EUR | 308.78% |
| 2018 Q4 | 3.37 Million EUR | -88.22% |
| 2018 Q1 | 9.99 Million EUR | 4.3% |
| 2018 FY | 48.99 Million EUR | 39.38% |
| 2017 Q3 | 9.58 Million EUR | 17.93% |
| 2017 FY | 35.15 Million EUR | -37.71% |
| 2017 Q4 | 9.58 Million EUR | -0.08% |
| 2017 Q2 | 8.13 Million EUR | 3.54% |
| 2017 Q1 | 7.85 Million EUR | 132.68% |
| 2016 Q1 | 49.92 Million EUR | 138.29% |
| 2016 Q2 | 18.19 Million EUR | -63.55% |
| 2016 Q3 | 12.34 Million EUR | -32.19% |
| 2016 Q4 | -24.02 Million EUR | -294.72% |
| 2016 FY | 56.43 Million EUR | -33.91% |
| 2015 Q2 | 16.41 Million EUR | -48.96% |
| 2015 Q1 | 32.16 Million EUR | 1963.12% |
| 2015 FY | 85.38 Million EUR | -93.03% |
| 2015 Q4 | 20.95 Million EUR | 32.18% |
| 2015 Q3 | 15.85 Million EUR | -3.45% |
| 2014 Q4 | 1.55 Million EUR | -87.33% |
| 2014 Q2 | -184.43 Million EUR | -113.21% |
| 2014 FY | 1.22 Billion EUR | 1314.59% |
| 2014 Q3 | 12.3 Million EUR | 106.67% |
| 2014 Q1 | 1.39 Billion EUR | 6643.67% |
| 2013 Q3 | 17.09 Million EUR | -32.17% |
| 2013 Q4 | 20.7 Million EUR | 21.13% |
| 2013 FY | 86.64 Million EUR | -3.39% |
| 2013 Q2 | 25.19 Million EUR | 6.54% |
| 2013 Q1 | 23.65 Million EUR | 10.42% |
| 2012 Q3 | 19.64 Million EUR | 25.48% |
| 2012 Q2 | 15.65 Million EUR | -52.83% |
| 2012 Q1 | 33.18 Million EUR | -15.66% |
| 2012 FY | 89.68 Million EUR | -42.55% |
| 2012 Q4 | 21.42 Million EUR | 9.05% |
| 2011 Q2 | 45.16 Million EUR | 23.36% |
| 2011 Q1 | 36.61 Million EUR | -0.26% |
| 2011 Q3 | 34.99 Million EUR | -22.51% |
| 2011 Q4 | 39.34 Million EUR | 12.42% |
| 2011 FY | 156.11 Million EUR | 7.61% |
| 2010 Q1 | 33.2 Million EUR | -0.64% |
| 2010 FY | 145.06 Million EUR | 10.19% |
| 2010 Q4 | 36.7 Million EUR | 5.03% |
| 2010 Q3 | 34.94 Million EUR | 0.32% |
| 2010 Q2 | 34.83 Million EUR | 4.93% |
| 2009 FY | 131.65 Million EUR | 7.34% |
| 2009 Q4 | 33.41 Million EUR | 10.03% |
| 2009 Q3 | 30.37 Million EUR | -7.72% |
| 2009 Q2 | 32.91 Million EUR | 7.05% |
| 2009 Q1 | 30.74 Million EUR | 0.0% |
| 2008 FY | 122.64 Million EUR | 15.38% |
| 2007 FY | 106.29 Million EUR | 1.04% |
| 2006 FY | 105.2 Million EUR | 25.72% |
| 2005 FY | 83.68 Million EUR | 9.52% |
| 2004 FY | 76.4 Million EUR | -4.13% |
| 2003 FY | 79.69 Million EUR | 6.08% |
| 2002 FY | 75.12 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 498.99 Million EUR | 92.242% |
| Fresenius SE & Co. KGaA | -594 Million EUR | 106.517% |
| LIMES Schlosskliniken AG | 3.39 Million EUR | -1039.766% |
| M1 Kliniken AG | 10.27 Million EUR | -276.785% |
| Maternus-Kliniken Aktiengesellschaft | -14.25 Million EUR | 371.53% |
| MEDICLIN Aktiengesellschaft | -10.77 Million EUR | 459.239% |
| VITA 34 AG | -1.86 Million EUR | 2175.71% |